2008
DOI: 10.1021/jm8000778
|View full text |Cite
|
Sign up to set email alerts
|

Conformationally Constrained Analogues of N-(Piperidinyl)-5-(4-Chlorophenyl)-1-(2,4- Dichlorophenyl)-4-Methyl-1H-Pyrazole-3-Carboxamide (SR141716): Design, Synthesis, Computational Analysis, And Biological Evaluations

Abstract: Structure-activity relationships (SARs) of 1 (SR141716) have been extensively documented, however, the conformational properties of this class have received less attention. In an attempt to better understand ligand conformations optimal for receptor recognition, we have designed and synthesized a number of derivatives of 1, including a four-carbon-bridged molecule (11), to constrain rotation of the diaryl rings. Computational analysis of 11 indicates approximately 20 kcal/mol energy barrier for rotation of the… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
12
0

Year Published

2010
2010
2015
2015

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 19 publications
(13 citation statements)
references
References 49 publications
1
12
0
Order By: Relevance
“…Next, we examined whether the inhibitory effect of CP55940 on LPS‐induced cytokine expression in CGCs was mediated by the CB 1 receptor. For this purpose, cells were treated with NESS0327, a potent CB 1 and CB 2 receptor antagonist [33,34] . NESS0327 (3 µ m ) did not reverse the inhibition of cytokine mRNA expression induced by CP55940 (Figure 5a–c), suggesting that CP55940 inhibited LPS‐induced cytokine mRNA expression in a manner independent of CB 1 and CB 2 .…”
Section: Resultsmentioning
confidence: 99%
“…Next, we examined whether the inhibitory effect of CP55940 on LPS‐induced cytokine expression in CGCs was mediated by the CB 1 receptor. For this purpose, cells were treated with NESS0327, a potent CB 1 and CB 2 receptor antagonist [33,34] . NESS0327 (3 µ m ) did not reverse the inhibition of cytokine mRNA expression induced by CP55940 (Figure 5a–c), suggesting that CP55940 inhibited LPS‐induced cytokine mRNA expression in a manner independent of CB 1 and CB 2 .…”
Section: Resultsmentioning
confidence: 99%
“…Support for the former conclusion was provided by the finding that rimonabant inhibited basal [ 35 S]GTPγS binding in brain membranes from CB 1 knock‐out mice (Breivogel et al ., 2001). Similar differences in potencies of novel CB 1 antagonists as neutral antagonists versus inverse agonists have also been reported in more recent studies (Thomas et al ., 2005; Zhang et al ., 2008). Moreover, rimonabant displays a similarly low potency in producing inverse agonist effects on cAMP production in brain membranes (Mato et al ., 2002).…”
Section: Cb1 Inverse Agonists Affect Other Gpcr Responsesmentioning
confidence: 99%
“…The methods used for performing binding assays in transfected cells expressing human CB1 or CB2 receptors were similar to those previously described for rat brain membrane preparations. 25, 35 Binding was initiated with the addition of 40 μg of cell membrane proteins to assay tubes containing [ 3 H]CP-55,940 (ca. 130 Ci/mmol) or [ 3 H]- 1 (ca.…”
Section: Receptor Binding Assaysmentioning
confidence: 99%